Protegrin-2, a potential inhibitor for targeting SARS-CoV-2 main protease Mpro

Zainab Jan, Anupriya M. Geethakumari, Kabir H. Biswas*, Puthen Veettil Jithesh

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

Background: SARS-CoV-2 variants continue to spread throughout the world and cause waves of COVID-19 infections. It is important to find effective antiviral drugs to combat SARS-CoV-2 and its variants. The main protease (Mpro) of SARS-CoV-2 is a promising therapeutic target due to its crucial role in viral replication and its conservation in all the variants. Therefore, the aim of this work was to identify an effective inhibitor of Mpro. Methods: We studied around 200 antimicrobial peptides using in silico methods including molecular docking and allergenicity and toxicity prediction. One selected antiviral peptide was studied experimentally using a Bioluminescence Resonance Energy Transfer (BRET)-based Mpro biosensor, which reports Mpro activity through a decrease in energy transfer. Results: Molecular docking identified one natural antimicrobial peptide, Protegrin-2, with high binding affinity and stable interactions with Mpro allosteric residues. Furthermore, free energy calculations and molecular dynamics simulation illustrated a high affinity interaction between the two. We also determined the impact of the binding of Protegrin-2 to Mpro using a BRET-based assay, showing that it inhibits the proteolytic cleavage activity of Mpro. Conclusions: Our in silico and experimental studies identified Protegrin-2 as a potent inhibitor of Mpro that could be pursued further towards drug development against COVID-19 infection.

Original languageEnglish
Pages (from-to)3665-3671
Number of pages7
JournalComputational and Structural Biotechnology Journal
Volume21
DOIs
Publication statusPublished - Jan 2023

Keywords

  • BRET assay
  • COVID-19
  • M
  • Protegrin-2
  • SARS-CoV-2, antimicrobial peptides

Fingerprint

Dive into the research topics of 'Protegrin-2, a potential inhibitor for targeting SARS-CoV-2 main protease Mpro'. Together they form a unique fingerprint.

Cite this